Adjuvant chemotherapy with gemcitabine plus erlotinib vs.gemcitabine alone for patients with resected pancreatic ductal adenocarcinoma:is there a role for erlotinib?—review of the open label phase III trial CONKO 005
摘要
Sinn et al. (1) report the results of a multicenter trial comparing the combination of gemcitabine and erlotinib with gemcitabine alone for adjuvant therapy in 436 patients who underwent R0 resection for pancreatic ductal carcinoma (PDAC).
-
1郭燕,吴雅珣,黄洁玉,陆晓云,陈旭东.胰腺导管癌中PD-L1的表达及其临床病理意义[J].临床与实验病理学杂志,2019,35(10):1177-1180. 被引量：2
-
2何铭,薛华丹,金征宇,赵玉沛.影像学检查在胰腺导管腺癌临床诊疗路径中的作用及价值[J].协和医学杂志,2019,10(1):11-18. 被引量：3
-
3科学家有望彻底攻克癌症之王-胰腺癌![J].现代医院,2017,17(9):1357-1357.
-
4冯卫能,邓秋梅.厄洛替尼联合抗血管生成药物对比厄洛替尼单药一线治疗EGFR突变晚期非小细胞肺癌的疗效[J].循证医学,2020,20(1):53-57. 被引量：4
-
5Andrew H. Ko.Moving from late to early stage disease: lessons learned from erlotinib in pancreatic cancer[J].Hepatobiliary Surgery and Nutrition,2018,7(5):406-408.
-
6Stefan Heinrich.Neoadjuvant therapy for pancreatic ductal adenocarcinoma—real effects or patient selection?[J].Hepatobiliary Surgery and Nutrition,2018,7(4):289-291.
-
7Hirohiko Shinkai,Tomoyuki Koike,Miki Shimada,Kenichiro Nakagawa,Katsunori Iijima,Yotaro Matsumoto,Masamitsu Maekawa,Nariyasu Mano,Tooru Shimosegawa.Influence of the Meal and Genotype of CYP2C19 on the Pharmacokinetics of Proton Pump Inhibitors in Healthy Japanese Subjects[J].Pharmacology & Pharmacy,2013,4(6):502-509.
-
8Oliver A. Kent.Increased mutant KRAS gene dosage drives pancreatic cancer progression: evidence for wild-type KRAS as a tumor suppressor?[J].Hepatobiliary Surgery and Nutrition,2018,7(5):403-405. 被引量：2
-
9Yasunori Minami,Masatoshi Kudo.Adjuvant therapy after radical surgery for hepatocellular carcinoma: still an unmet need[J].Hepatobiliary Surgery and Nutrition,2019,8(4):414-416.
-
10Lakshmi Kalyani Ruddaraju,Sri Venkata Narayana Pammi,Girija sankar Guntuku,Veerabhadra Swamy Padavala,Venkata Ramana Murthy Kolapalli.A review on anti-bacterials to combat resistance: From ancient era of plants and metals to present and future perspectives of green nano technological combinations[J].Asian Journal of Pharmaceutical Sciences,2020,15(1):42-59. 被引量：2
